We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Microarray Test Detects Pathogenic Shifts in the Taxonomic Distribution of Vaginal Bacteria

By LabMedica International staff writers
Posted on 31 Mar 2015
Print article
Image: Micrograph of bacterial vaginosis—cells of the cervix covered with rod-shaped bacteria, Gardnerella vaginalis (arrows) (Photo courtesy of Wikimedia Commons).
Image: Micrograph of bacterial vaginosis—cells of the cervix covered with rod-shaped bacteria, Gardnerella vaginalis (arrows) (Photo courtesy of Wikimedia Commons).
A team of Italian microbiologists has developed a microarray-based diagnostic tool that monitors the vaginal bacteria population and alerts the clinician to changes in taxonomic distribution that are characteristic of bacterial vaginosis.

Under normal conditions the population of bacteria in the vagina is generally dominated by lactobacilli that confer antimicrobial protection and play a crucial role in health. Bacterial vaginosis (BV) is the most prevalent lower genital tract infection in women in reproductive age and is characterized by a shift in the relative abundance of Lactobacillus spp. to greater abundance of strictly anaerobic bacteria such as Gardnerella vaginalis, Atopobium vaginae, Mycoplasma hominis, various species of Prevotella and others.

Investigators at the University of Bologna (Italy) have reported the development of a microarray based test system that they call "VaginArray". This assay was based on 17 DNA probe sets, each being specific for one of the representative bacterial species inhabiting the vaginal ecosystem. Each set was designed to be complementary to the "variable region" of the 16S rRNA of its target gene and the match must be exact in order to register as positive. The target bacteria were identified and quantified by measuring the fluorescence intensity produced by each probe set.

In practice, the entire probe set properly recognized the specific targets and showed an overall sensitivity of 6 to12 nanograms per each probe. As a practical exercise the VaginArray was applied to assess the efficacy of rifaximin vaginal tablets for the treatment of BV. The investigators analyzed the vaginal bacterial communities of 22 BV-affected women treated with 25 milligrams/day rifaximin vaginal tablets for five days. Results showed the ability of rifaximin to reduce the growth of various BV-related bacteria. Furthermore, an increase of Lactobacillus crispatus was observed in the subset of women who maintained remission after one month of therapy.

"Our microarray could be used to study alterations of the vaginal ecology associated with gynecologic disorders and to assess the impact of therapeutic agents on the vaginal microbiota," said senior author Dr. Beatrice Vitali, professor of pharmacy and biotechnology at the University of Bologna.

The paper describing VaginArray was published in the March 2, 2015, online edition of the journal Antimicrobial Agents and Chemotherapy.

Related Links:

University of Bologna


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.